Comments
Loading...

United Therapeutics

UTHRNASDAQ
Logo brought to you by Benzinga Data
$351.33
8.742.55%
At Close: -
$351.33
00.00%
After Hours: 4:40 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$575.00
Lowest Price Target1
$240.00
Consensus Price Target1
$324.25

United Therapeutics (NASDAQ:UTHR) Stock, Analyst Ratings, Price Targets, Forecasts

United Therapeutics Corp has a consensus price target of $324.25 based on the ratings of 17 analysts. The high is $575 issued by Oppenheimer on August 28, 2024. The low is $240 issued by Goldman Sachs on May 3, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, Wells Fargo, and HC Wainwright & Co. on August 28, 2024, August 20, 2024, and August 1, 2024, respectively. With an average price target of $451.67 between Oppenheimer, Wells Fargo, and HC Wainwright & Co., there's an implied 28.56% upside for United Therapeutics Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
2
1
May
1
Jun
1
Jul
2
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
Wells Fargo
HC Wainwright & Co.
B of A Securities
TD Cowen

1calculated from analyst ratings

Analyst Ratings for United Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for United Therapeutics (UTHR) stock?

A

The latest price target for United Therapeutics (NASDAQ:UTHR) was reported by Oppenheimer on August 28, 2024. The analyst firm set a price target for $575.00 expecting UTHR to rise to within 12 months (a possible 63.66% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for United Therapeutics (UTHR)?

A

The latest analyst rating for United Therapeutics (NASDAQ:UTHR) was provided by Oppenheimer, and United Therapeutics maintained their outperform rating.

Q

When was the last upgrade for United Therapeutics (UTHR)?

A

The last upgrade for United Therapeutics Corp happened on February 12, 2024 when Goldman Sachs raised their price target to $215. Goldman Sachs previously had a sell for United Therapeutics Corp.

Q

When was the last downgrade for United Therapeutics (UTHR)?

A

The last downgrade for United Therapeutics Corp happened on July 11, 2024 when Morgan Stanley changed their price target from $310 to $321 for United Therapeutics Corp.

Q

When is the next analyst rating going to be posted or updated for United Therapeutics (UTHR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of United Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for United Therapeutics was filed on August 28, 2024 so you should expect the next rating to be made available sometime around August 28, 2025.

Q

Is the Analyst Rating United Therapeutics (UTHR) correct?

A

While ratings are subjective and will change, the latest United Therapeutics (UTHR) rating was a maintained with a price target of $400.00 to $575.00. The current price United Therapeutics (UTHR) is trading at is $351.33, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch